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Abstract 
 
Background: Intraoral minor salivary glands tumors (MSGT) are uncommon, with geographic variations in 
frequency and distribution. This study analyzed the clinic-pathologic features of these tumors in Shiraz, south-
ern Iran. 
 
Methods: All of cases histopathologically recorded as epithelial MSGT in Pathology Department of Khalili Hospi-
tal from 2002 to 2009 were evaluated with regard to patient's age and gender, tumor location and type, retro-
spectively.  
 
Results: Out of 82 cases of MSGT, 53.7% were benign and 46.3% were malignant. Pleomorphic adenoma and 
adenoid cystic carcinoma were the most common benign and malignant tumors, respectively. The palate was the 
most common site of involvement (64.6%). Male to female ratio was 1:1.27. The mean age of the patients was 
35.0±17.2 years for benign and 48.8±18.2 years for malignant tumors. 
 
Conclusion: MSGTs in the present study represent many characteristics of other studies. However, our patients 
who were affected by benign tumors were young. 
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Introduction 
 
Minor salivary glands are functional structures locat-
ed in the submucosa of the upper aerodigestive tract.
1 
The importance of the lesions lies in the fact that le-
sions are more likely to be malignant.
2 Studies from 
other countries report that 13.9-51.4% of all salivary 
gland tumors (SGTs) arise from an intraoral area and 
34.7-67.1% of them are benign.
3-6 It was shown that 
incidence of SGTs is influenced by geographic and 
racial factors.
7,8 Up to now, a large series of  MSGTs 
were reported in Iran. The aim of this study was to 
determine clinic-pathological features of 82 cases of 
benign and malignant intraoral MSGT in this region. 
 
Materials and Methods 
 
All of 82 histopathological approved cases recorded as 
epithelial SGT in the oral mucosa and jaws location in 
Pathology Department of Khalili Hospital, ENT center 
affiliated to Shiraz University of Medical Sciences in 
Southern Iran, from 2005 to 2009 were enrolled. Re-
current, metastatic and non-epithelial neoplasms were 
excluded. The cases were evaluated with regard to pa-
tient's age and gender, tumor location and histopatho-
logic type according to the 2005 WHO classification, 
through a retrospectively review of the patients’ medi-
cal files. They were analyzed using SPSS software 
(version 11.5, Chicago, IL, USA). 
 
 
Results 
 
Among 356 SGTs, 82 cases (23%) were recorded as 
epithelial SGT in the oral mucosa and jaws. Forty 
four (53.7%) were benign and 38 cases (46.3%) were 
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malignant (Table 1). The patients were between 13 to 
80 years, with a mean of 41.4±18.9. The palate was 
the most common site of involvement in both benign 
and malignant types, corresponding to 64.6% of all 
cases (Figure 1). Five cases of tumors (7.4%), includ-
ing one case of pleomorphic adenoma (PA), one case 
of polymorphous low-grade adenocarcinoma (PLGA) 
and 3 cases of mucoepidermoid carcinoma (MEC) 
were centrally located in the maxilla and mandible. 
Overall male to female (M/F) ratio was 1:1.27. Table 1 
shows the type, age and gender distribution of tumors. 
 
 
Discussion 
 
To the present time, little data is available on the clin-
ic-pathologic presentation of MSGTs in Iran. We 
studied these cases in an ENT center during a 5 years 
period. Among 9700 cases, MSGTs were uncommon, 
representing 0.84% of all the biopsy specimens. In-
traoral MSGTs accounted for 0.28-1.9% of the spec-
imens, as reported by other authors in USA, Japan, 
Venezuela and Thailand.
4,9-11 
In our series, malignant neoplasms constituted 
46.3% of the cases which is in agreement with the re-
sults of the most previous studies.
5,9,12 However, some 
have shown a predominance of malignant tumors.
6,9,13-
15 Most of these researches performed in special situa-
tions such as cancer registry and cancer treatment cen-
ters. In the current study, PA was the most common 
tumor, representing 43.9% of all and 81.8% of the be-
nign tumors, which is comparable with other series that 
reported the incidence of this entity from 15.8
14 to 78 
%
16of cases (Figure 2).
2-6,9-11,14,16 
Table 1: Type, age and gender distribution of minor salivary glands
a.
Tumor type  Frequency (%) M:F Mean age±SD  Age range
Benign tumors  44 (53.7)  22:22  35±17.25  13-72 
PA 36  (43.9)  16:20  34.5±2.7  13-72 
Myoepithelioma 7  (8.5)  6:1  39±8.5  19-71 
Monomorphic adenoma  1 (1.2)  0:1  23  23 
Malignant tumors  38 (46.3)  36:46  48.8±18.1  13-80 
MEC 10  (12.2)  3:7  43.7±5.2  15-63 
ACC 1  (1.2)  0:1  60  60 
AdCC 23  (28.0)  10:13  50.8±4  13-80 
ca.ex.PA 1  (1.2)  0:1  67  67 
PLGA 3  (3.7)  1:2  41±7.6  26-51 
Total 82  (100.0)  58:68  41.4±18.9  13-80 
a PA: pleomorphic adenoma, MEC: mucoepidermoid carcinoma, ACC: acinic cell carcinoma, AdCC: adenoid cystic 
carcinoma, ca.ex.PA: carcinoma ex pleomorphic adenoma, PLGA: polymorphous low-grade carcinoma 
 
 
Fig. 1: Location of benign and malignant tumors. L: lower, U: upper, M: mucosa, BM: Buccal mucosa Jaafari-Ashkavandi et al. 
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Among malignant tumors, Ad CC was the most 
common. Figure 2 is similar to some reports,
14,15,17 but 
the authors in USA, Brazil, Venezuela, Australia, 
China and Ansari on 18 cases of MSGTs in central 
Iran, reported that MEC was the most frequent.
6,10,16, 
18- 21   According to these data, there is a geographic 
variation in relative frequency of Ad CC versus MEC. 
However, these two neoplasms are the first and se-
cond malignant tumors in the most series. 
The palate was the most common site of involve-
ment in our findings (64.6%), followed by buccal 
mucosa. The palate accounted for 34.6
 21- 82.9%
11 of 
cases in previous studies. This location was the most 
commonly affected site for both benign and malig-
nant neoplasms, but benign tumors were predomi-
nant. This finding is in agreement with other stud-
ies.
3,4,11,20   Our results showed that the tongue (8.5%) 
and jaws (7.3%) were the next sites. Similar to our 
findings, Dhanuthai et al., and Jabber et al. reported 
6.5% and 5.2% of MSGTs in the jaws.
11,21 
The peak prevalence of benign tumors occurred in 
the third decade of life and that of malignant types 
were in the 6
th and 7
th. Really, the mean age of malig-
nant tumors was 13.8 years later than benign ones. 
This difference was higher in our population than the 
previous studies, reporting a range from 2.9 years in 
Thais to 13.3 years in African population.
11,22   This 
finding is due to the fact that in our series, patients 
with benign tumors were younger (mean age: 35) 
while others have stated that the mean age of the af-
fected patients with these neoplasms was from 40 in 
Chinese to 49 in Japanese.
3,4 
Overall, the incidence of MSGTs was higher in fe-
males (M/F ratio was 1:1.27).  This ratio was reported 
from 1:1.02
15 to 1:2.
10 It has been suggested that gender 
distribution in SGTs is related to ethnic variations.
4,22 
In conclusion, in the present population, PA was 
the most common neoplasm, the palate was the most 
commonly affected site, and female tendency of 
MSGTs was seen. Ad.CC was the most common ma-
lignancy as some other Asian nations. However, our 
patients affected by benign tumors were younger. Our 
findings could help us to perform better diagnosis and 
early treatment for this group of patients. 
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Fig. 2: Incidence of benign and malignant tumors in each decade 
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